文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

刚果(金)5岁以下住院儿童非伤寒沙门菌血流感染的药敏匹配抗菌治疗疗效:一项前瞻性观察研究

Efficacy of susceptibility-matched antibiotic treatment of nontyphoidal Salmonella bloodstream infections: a prospective observational study in hospitalized children under 5 in the Democratic of Congo.
PubMed 文献 · Clin Microbiol Infect · 2025-12-20

该前瞻性观察研究在刚果(金)Kisantu地区医院纳入1867名严重发热住院儿童,其中12.7%诊断为非伤寒沙门菌血流感染,60%为广泛耐药。仅64%患儿接受药敏匹配抗生素,住院病死率25.1%;匹配的第三代头孢菌素、环丙沙星或阿奇霉素治疗与改善生存相关。

要点

  • NTS血流感染占严重发热住院儿童的12.7%,广泛耐药率达60%。
  • 仅64%患儿接受药敏匹配抗生素,总体住院病死率25.1%。
  • 匹配的第三代头孢菌素、环丙沙星或阿奇霉素治疗与生存改善相关。

核心结论

  • NTS血流感染常为广泛耐药,导致药敏不匹配治疗,匹配的第三代头孢菌素、环丙沙星或阿奇霉素治疗可能有效。

研究设计与样本

  • 前瞻性观察研究,纳入刚果(金)Kisantu地区医院年龄>28天至<5岁的严重发热住院儿童,血培养采样后入组。

主要发现

  • NTS血流感染诊断率为12.7%(239/1867)。
  • 广泛耐药(同时对氨苄西林、复方磺胺甲噁唑、氯霉素、第三代头孢菌素和氟喹诺酮类不敏感)占60%(144/236)。
  • 仅64%(146/228)患儿接受药敏匹配抗生素,总住院病死率为25.1%(60/239)。
  • 与药敏不匹配治疗相比,药敏匹配的第三代头孢菌素治疗(住院第0-1天)14天住院生存更优(死亡风险比HRdeath:0.37 [0.16-0.88])。
  • 药敏匹配的第三代头孢菌素、环丙沙星或阿奇霉素治疗(住院第2-6天)28天住院生存更优(HRdeath分别为0.21 [0.06-0.68]、0.15 [0.02-1.10]和0.26 [0.08-0.84])。

关键数值与推荐

  • NTS血流感染在O5抗原阳性Typhimurium血清型中广泛耐药占69%(71/103),O5抗原阴性Typhimurium中占85%(72/85),Enteritidis血清型中仅2%(1/48)。
  • 药敏匹配抗生素治疗≥5天后,对照血培养中NTS持续存在者占15%(13/88)。

临床怎么用

  • 在NTS血流感染高发且广泛耐药地区,应尽早依据药敏结果选用匹配的第三代头孢菌素、环丙沙星或阿奇霉素治疗。
  • 治疗第5天后应考虑复查血培养以评估微生物学清除。

局限性

  • 本研究为观察性设计,可能存在未测量混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: In sub-Saharan African children aged under 5 years, nontyphoidal Salmonella (NTS) frequently cause fatal bloodstream infections. Antimicrobial resistance and absence of antibiotic treatment efficacy data challenge effective treatment. In this prospective observational study, we provide treatment efficacy data of susceptibility-matched antibiotic regimens from the treatment of NTS bloodstream infections in children in Kisantu district hospital (Democratic Republic of Congo). METHODS: Children (>28 days to <5 years) admitted with severe febrile illness were enrolled after blood culture sampling. Clinical and microbiological data of children with NTS bloodstream infection were collected in-hospital and at 1-month after discharge. RESULTS: NTS bloodstream infection was diagnosed in 12.7% (239/1867) of enrolled children. Extensive drug-resistance (concurrent ampicillin, cotrimoxazole, chloramphenicol, third-generation cephalosporin and fluoroquinolone nonsusceptibility) occurred in 60% (144/236), i.e. 69% (71/103) in O5-antigen positive Typhimurium, 85% (72/85) in O5-antigen negative Typhimurium but only 2% (1/48) in Enteritidis serovars. Only 64% (146/228) of children received susceptibility-matched antibiotics and overall in-hospital case fatality was 25.1% (60/239). Compared with susceptibility-mismatched antibiotic treatment, susceptibility-matched third-generation cephalosporin treatment on hospital day 0-1 had better 14-day in-hospital survival (hazard ratio at death [HRdeath]: 0.37 [0.16-0.88]). Similarly, susceptibility-matched third-generation cephalosporin, ciprofloxacin or azithromycin treatment on hospital day 2-6 had better 28-day in-hospital survival (HRdeath: 0.21 [0.06-0.68], 0.15 [0.02-1.10] and 0.26 [0.08-0.84], respectively). After ≥5 days of susceptibility-matched antibiotics, NTS persisted in control blood cultures in 15% (13/88). CONCLUSIONS: NTS bloodstream infections were often extensively drug resistant, leading to susceptibility-mismatched antibiotic treatment. When NTS were susceptible, third-generation cephalosporin, ciprofloxacin and azithromycin treatment appeared to be effective.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Tack B, Vita D, Mbuyamba J, et al. Efficacy of susceptibility-matched antibiotic treatment of nontyphoidal Salmonella bloodstream infections: a prospective observational study in hospitalized children under 5 in the Democratic of Congo. Clin Microbiol Infect. 2025. PMID: 41429348. doi:10.1016/j.cmi.2025.12.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。